Comprehensive TB Elimination Act of 2021

Comprehensive TB Elimination Act of 2021

This bill reauthorizes for FY2022-FY2027 and revises the tuberculosis (TB) prevention and treatment grant program administered by the Centers for Disease Control and Prevention. The Health Resources and Services Administration may also award grants to state, tribal, territorial, and local governments and specified health care providers (e.g., Native Hawaiian health organizations and federally qualified health centers) for TB prevention and treatment efforts.

Additionally, the Government Accountability Office must report on (1) national TB prevention and treatment efforts, and (2) matters concerning TB drug shortages and costs.

Bill 117 HR 5857, also known as the Comprehensive TB Elimination Act of 2021, is a piece of legislation introduced in the US Congress with the goal of addressing the issue of tuberculosis (TB) in the United States.

The bill aims to provide funding and resources for the prevention, diagnosis, and treatment of TB, as well as for research into new and more effective treatments. It also seeks to improve coordination between federal, state, and local health agencies in order to better track and respond to TB outbreaks.

Additionally, the Comprehensive TB Elimination Act of 2021 includes provisions for increasing public awareness about TB, particularly in at-risk communities, and for supporting efforts to reduce the stigma associated with the disease. Overall, the bill is designed to strengthen the nation's response to TB and to work towards the goal of eliminating the disease in the United States. It represents a bipartisan effort to address a serious public health issue and to improve the health and well-being of all Americans.